Latent blog · Jul 2026
Product launch/guidance post introducing support for the Medicare GLP-1 Bridge to help pharmacy teams process eligibility.
Medical language models to automate healthcare operations
Latent blog · Jul 2026
Product launch/guidance post introducing support for the Medicare GLP-1 Bridge to help pharmacy teams process eligibility.
Latent blog · Jun 2026
Research/product release describing CIPHER, a 1.5B-parameter clinical de-identification model with 97.9% recall on PHI redaction at lower inference cost.
Business Wire · Apr 2026
Series A announcement: Latent raised $80M co-led by Spark Capital and Transformation Capital, with participation from Conviction, McKesson Ventures, General Catalyst, and Y Combinator.
Forbes · Mar 2026
Profile on Latent’s growth and valuation; reports the company reached roughly a $600M valuation after the Series A and highlighted its AI agents for prior authorization.
Becker's Hospital Review · Dec 2025
Major partnership/milestone coverage on Mount Sinai’s digital-first pharmacy adoption with Latent, including reduced task completion times.